Plasma lipids affect dabigatran etexilate anticoagulation in rats with unbalanced diabetes mellitus-Reference-Cited by-同舟云学术

Plasma lipids affect dabigatran etexilate anticoagulation in rats with unbalanced diabetes mellitus

Published:2017-09-13 Issue:3 Volume:10 Page:240-248
ISSN:1753-0393
Container-title:Journal of Diabetes
language:en
Short-container-title:Journal of Diabetes

Author:

Scridon Alina¹²,Perian Marcel²,MĂrginean Alina²³,Huţanu Adina¹²⁴,Gherţescu Doina²,Vântu Adriana²,FişcĂ Paul C.²,Chevalier Philippe⁵,Şerban Răzvan C.²⁶,Dobreanu Dan²⁶

Affiliation:

1. Laboratory of Functional Explorations; Center for Advanced Medical and Pharmaceutical Research; Tîrgu Mureş Romania

2. Physiology Department; University of Medicine and Pharmacy of Tîrgu Mureş; Tîrgu Mureş Romania

3. Department of Medical Laboratory; Emergency Military Hospital “Dr. Constantin Papilian,”; Cluj-Napoca Romania

4. Department of Medical Laboratory; Emergency Clinical County Hospital; Tîrgu Mureş Romania

5. Service de Rythmologie; Hôpital Louis Pradel; Lyon France

6. Laboratory of Cardiac Catheterization, Angiography, and Electrophysiology; Emergency Institute for Cardiovascular Diseases and Transplantation; Tîrgu Mureş Romania

Funder

University of Medicine and Pharmacy of Tîrgu Mureş

Boehringer Ingelheim GmbH

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1753-0407.12580/fullpdf

Reference44 articles.

1. Dabigatran versus warfarin in patients with atrium fibrillation;Connolly;N Engl J Med.,2009

2. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med.,2011